Glucagon, Insulin and the Hormonal Switch in Ketosis
The ketogenic diet works by altering two key pancreatic hormones: insulin and glucagon. These hormones act as opposing forces in fuel metabolism, determining whether your body stores fat or burns it. Understanding their interplay explains why carbohydrate restriction shifts energy production towards ketones.
The Insulin-Glucagon Seesaw
Insulin, released by pancreatic beta cells, dominates after carbohydrate consumption. It signals cells to absorb glucose from the bloodstream, inhibits fat breakdown in adipose tissue, and promotes fat storage. Glucagon, secreted by pancreatic alpha cells, rises when blood glucose falls. It triggers glycogen breakdown in the liver and stimulates fat release from adipose tissue.
A 2013 meta-analysis found very-low-carbohydrate diets significantly increase glucagon secretion while reducing insulin levels compared to low-fat diets (Bueno et al., 2013). This hormonal rebalancing is the metabolic foundation of nutritional ketosis.
The Hormonal Switch Mechanism
When carbohydrate intake drops below 50 g daily, insulin secretion decreases sharply. With less insulin suppression, glucagon can activate hormone-sensitive lipase (HSL), the enzyme that releases fatty acids from fat cells. These fatty acids travel to the liver, where glucagon directs their conversion into ketone bodies.
the keto adaptation timeline typically takes 3-7 days as the body shifts from glucose dependence to ketone utilisation. During this period, glucagon’s role becomes critical in maintaining energy supply.
What This Means in Practice
In the UK, seasonal eating patterns often work against this hormonal switch. Winter comfort foods like potatoes and bread at Tesco (a 2 kg bag of Maris Pipers costs £1.85) keep insulin elevated. Switching to glucagon-supporting foods—such as leafy greens, eggs, and fatty fish—helps initiate the transition. A 200 g bag of spinach at Sainsbury’s costs 85p and provides fibre without spiking insulin.
Those with insulin resistance may find the switch takes longer. Research from Virta Health shows people with type 2 diabetes often require 2-4 weeks to achieve consistent ketosis (Hallberg et al., 2018).
Appetite Regulation and Satiety
Glucagon has an often-overlooked role in appetite suppression. Unlike insulin, which drops after meals and can trigger hunger, glucagon promotes satiety signals. A 2013 study found ketogenic diets increase glucagon-like peptide-1 (GLP-1), a hormone that reduces food cravings (Sumithran et al., 2013).
common keto electrolyte mistakes like neglecting sodium intake can temporarily mask these benefits by causing false hunger signals.
Frequently Asked Questions
Does fasting produce the same hormonal switch?
Yes. Fasting lowers insulin and raises glucagon more rapidly than a ketogenic diet alone. Combining intermittent fasting with keto can accelerate the transition, but it’s not necessary for everyone.
Can you measure glucagon at home?
No. Unlike ketone meters, glucagon tests require clinical labs. Focus on indirect signs: stable energy, reduced hunger, and measurable ketones (0.5-3.0 mmol/L on blood tests).
Do artificial sweeteners affect glucagon?
Some evidence suggests sweeteners like sucralose may provoke insulin secretion despite lacking calories, potentially slowing the hormonal switch. Stick to unsweetened drinks or small amounts of stevia.
The Bottom Line
Glucagon and insulin act as a metabolic switchboard, determining whether your body stores or burns fat. The ketogenic diet flips this switch by lowering carbohydrate intake, reducing insulin dominance, and allowing glucagon to mobilise fat stores. While individual responses vary—especially for those with metabolic conditions—the hormonal shift explains why keto aids fat loss without calorie counting. If you’d rather not do the macro maths yourself, the Keto Dieting app does it for you on Google Play and the App Store.
References
- Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T (2013). Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. British Journal of Nutrition. https://doi.org/10.1017/S0007114513000548
- Hallberg SJ, McKenzie AL, Williams PT, et al. (2018). Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Therapy. https://doi.org/10.1007/s13300-018-0373-9
- Sumithran P, Prendergast LA, Delbridge E, et al. (2013). Ketosis and appetite-mediating nutrients and hormones after weight loss. European Journal of Clinical Nutrition. https://doi.org/10.1038/ejcn.2013.90
